Ximena Jordan Bruno

Nicos mom, relentless IMG Hematologist, @UCCoficial,@Udelaruy @UVMVermont alumna.Learning from patients with leukemia and BM failure. Genetic risk enthusiast

[Ximena Jordan Bruno @XimeJordan]

In beautiful Cochabamba learning a lot and very happy with Profesor Amaru’s gift à book about Epidemiology of leukemias in Bolivia 🇧🇴 🙌🙏 here with him and Dr Scott Howard from St Jude

[International CML Foundation @icmlf]

Join us online on October 19th for an expert webinar, featuring key insights from the ESH-iCMLf 28th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy.

🌍 Online
🔗 Check out the program and register now: https://t.co/OTJk1BuLTG

[Ximena Jordan Bruno @XimeJordan]

Amazing topic!

[Dr. Estela Rodriguez @Latinamd]

Delighted to be invited again to speak on one of my favorite topics: "Building TRUST in Clinical Trials" and eradicating barriers to #clinicaltrialenrollment at the @SylvesterCancer Design & Management of Clinical Trials Course
Some pearls:
▶️Ask every eligible patient
▶️Earn trust before the trial, show up where pts are
▶️Match language and culture
▶️Use navigators to ensure retention from day one
#clinicaltrialdiversity

[Ximena Jordan Bruno @XimeJordan]

Excited to travel back to Bolivia���❤️
Emocionada de volver à Bolivia y compartir ideas con mis colegas y amigos ⭐️👋🏼 ✨
Thanks to Dr Rocio Baena and Dr Jose Macias for the invitation. They sent me a pic as a reminder of the spectacular landscape waiting ✨✨⭐️🥰

[Kelly Bolton MD PhD @KellyLBolton]

Chemotherapy and ionizing radiation are known to promote clonal hematopoiesis and its progression to leukemia. By inducing temporary quiescence of hematopoietic stem cells during external stress might we mitigate CH expansion? We address this through a collaboration with @AbdelWahablab @PuZhang09980432: https://t.co/DUExKVNRSg. Excited to share this and some thoughts from a recent meeting in Hiroshima which puts this work in a broader perspective.

[Ximena Jordan Bruno @XimeJordan]

🙌✨⭐️ congratulations to all the authors! Thank you for bringing more options for our patients with AML
https://t.co/VuxnKIYTof

[Ximena Jordan Bruno @XimeJordan]

@GomezDLeonMD @HumbertoMar_Cor Wow mil Felicidades!!!

[Ximena Jordan Bruno @XimeJordan]

@ChrisLandauUSA Saltenas are the best no doubt! :)

[Benlazar S M A @smbenlazar]

AML with inv (16)(p13.1;q22) or t(16;16)(p13.1;q22); CBFB::MYH11 #AML #leusm

[Benlazar S M A @smbenlazar]

APL with t(15;17)(q24.1;q21.2); PML::RARA
>>> Phenotypic clues that predict underlying cytogenetic/genetic abnormalities in myeloid malignancies: A contemporary review - Stone - 2023 - Cytopathology - Wiley Online Library https://t.co/eYR9kSfNAt #AML #leusm

[Benlazar S M A @smbenlazar]

From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia https://t.co/CylMHmnKoI #CML #leusm

[Marlise R. Luskin MD, MSCE @LuskinMarlise]

VEN plus INO for RR CD22 ALL - excellent outcomes for a high risk disease - so much more work to be done but a small step forward for our patients! @DanaFarber @DanaFarberNews https://t.co/RqTmkbRR0B

[Benlazar S M A @smbenlazar]

How I treat anemia in myelofibrosis #MPNSM https://t.co/drbjxP2CFq

[Ximena Jordan Bruno @XimeJordan]

😆🙌😅😉

[NEJM @NEJM]

In an international cohort of 865 patients, Shwachman–Diamond syndrome was associated with a high risk of myeloid cancer and poor survival. Early hematopoietic stem-cell transplantation for high-risk features had a potential benefit. Full study results: https://t.co/dmkvgaInzw

[Senda_Verde @La_Senda_Verde]

We wanted to thank you all for being part of this community and helping us :)

[RUNX1 Research Program @RUNX1Research]

Led by the @Penn and supported by RRP,the RUNX1 Patient Tissue Bank provides approved researchers with de-identified blood and bone marrow samples to study RUNX1-FPD biology, develop earlier blood cancer detection methods, improve quality of life, and work toward prevention.

Patients can contribute a small blood or bone marrow sample during a routine appointment at their local clinic, without additional travel.

If you care for patients with RUNX1-FPD, please share this research opportunity with them.

Learn more: https://t.co/aTZ7n5uSyb

[Andrés Jerez @anjecayu]

OJO: jornada de predisposición germinal el 17 de Noviembre en Madrid. Registro presencial/virtual gratuito. Discutiremos desde qué tejido germinal utilizar, cómo modifica la selección de donantes...hasta telomeropatías en el adulto.Aprenderemos seguro.
https://t.co/CYAqQqLm5y

[Ximena Jordan Bruno @XimeJordan]

@CarmeloGurnari @MosqueraOrgeira @AIRC_it @Unicatt @unitorvergata2 Wow 🤩 congratulations!!!